ACTIVE SINCE: 1985
GSK Vaccine Partnerships with FioCruz and Funed
Manufacturing vaccines for public health priorities in Brazil including polio, Haemophilus influenzae type b (Hib), measles, mumps, rubella, rotavirus, pneumococcal and meningococcal vaccines.
SGDS CONTRIBUTING TO:
PARTNERING WITH:
SEE ALL PARTNER ORGANIZATIONS
SEE ALL PARTNER ORGANIZATIONS
Academia or research institute 1
Government 1
Objectives
Technology transfer and product supply agreements for polio; measles, mumps, rubella and varicella (MMR&V); rotavirus; pneumococcal vaccines and meningococcal C vaccine.
GSK has been partnering with Brazil’s Oswaldo Cruz Foundation (FioCruz) since 1985 to manufacture vaccines for public health priorities in Brazil including polio, Haemophilus influenzae type b (Hib), MMR (measles, mumps, rubella) MMRV (measles, mumps, rubella, varicella) , rotavirus and, pneumococcal vaccines.
GSK is also partnering with Ezequiel Dias Foundation (Funed) to produce a Meningococcal C vaccine.
Geographic Reach
- Americas
Disease Area
- Infectious and Parasitic Disease
- Vaccine preventable disease
Target Population
- Children
- Elderly
- Men
- Women
- Youth
SGDs the partnership contributes to
SDG 3: Good Health and Wellbeing
- 3.2: Reduce Under-5 Mortality
- 3.3: Communicable Diseases & NTDs
- 3.8: Achieve universal health coverage
SDG 5: Gender Equality
SDG 9: Industry Innovation and Infrastructure
SDG 10: Reduced Inequalities
SDG 17: Partnerships for the Goals
Partner organizations
Academia or research institute
Fundação Oswaldo Cruz (FIOCRUZ)
Government
Ministry of Health Brazil
Additional information
Geographic Reach
Americas
- Brazil
Disease Area
Infectious and Parasitic Disease
- Polio
- Rotavirus
- Rubella
- Haemophilus influenzae type b (Hib)
- Meningococcal A, C, W, Y
- Influenza
- Measles
- Mumps
- Pneumococcal Disease